Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162262 · ClinicalTrials.gov registry record · NA
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
A NA study of Plantar Fascitis, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT04162262: Completed NA study of Plantar Fascitis, sponsored by Texas Tech University Health Sciences Center.
NCT04162262 is a NA study of Plantar Fascitis that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 83 participants, roughly in line with the 84-participant average among 7 other Plantar Fascitis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04162262, a NA study of Plantar Fascitis, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the addition instrument-assisted soft tissue mobilization (IASTM) to a program of home strengthening and stretching exercises to see whether adding weekly IASTM treatments improves plantar fasciopathy pain and plantar fascia stiffness.
Primary Outcome
This self-report questionnaire assesses individuals' foot health and function. The pain subscale evaluates type of pain and its severity and duration.
Conditions Studied
Interventions
- OTHER Instrumental-assisted soft tissue mobilization (IASTM)
- OTHER High-Load Strength Training
- OTHER Plantar Flexor and Gastrocnemius Stretching
Study Locations (1)
Texas
- Texas Tech University Health Sciences Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2021-01-15 |
| Phase | NA |
What the finished NCT04162262 record still lists
NCT04162262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, roughly in line with the 84-participant average among 7 other Plantar Fascitis trials with a reported enrollment target.
The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 3 interventions - of which Instrumental-assisted soft tissue mobilization (IASTM) is the first listed.
NCT04162262 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04162262 about?
NCT04162262 is a clinical study titled "Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment". This study compares the addition instrument-assisted soft tissue mobilization (IASTM) to a program of home strengthening and stretching exercises to see whether adding weekly IASTM treatments improves plantar fasciopathy pain and plantar fascia stiffness.
What is the current status of trial NCT04162262?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2019-10-24. Estimated completion is 2021-01-15.
What conditions does trial NCT04162262 study?
This clinical trial studies the following conditions: Plantar Fascitis.
What interventions are being tested in trial NCT04162262?
The interventions under investigation include: Instrumental-assisted soft tissue mobilization (IASTM) (OTHER), High-Load Strength Training (OTHER), Plantar Flexor and Gastrocnemius Stretching (OTHER).
Who is sponsoring clinical trial NCT04162262?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04162262 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fascitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Versus Static Night Splinting of Plantar Fasciitis
RECRUITING · NA
-
Plantar Fasciitis Randomized Clinical Control Trial
RECRUITING · NA
-
HP Arize 3D Orthotics for Planar Fasciitis
ACTIVE NOT RECRUITING · NA
-
Shockwave Therapy for Plantar Fasciitis RCT
ACTIVE NOT RECRUITING · NA
-
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
COMPLETED · NA
-
Acupuncture for Plantar Fasciosis in the Primary Care Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI